ME Therapeutics Holding (XCNQ:METX) EV-to-EBITDA : -14.89 (As of May. 21, 2024)

ME Therapeutics Holding EV-to-EBITDA Chart

Competitive Comparison of ME Therapeutics Holding's EV-to-EBITDA

For the Biotechnology subindustry, ME Therapeutics Holding's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's EV-to-EBITDA falls into.

ME Therapeutics Holding EV-to-EBITDA Calculation

ME Therapeutics Holding's EV-to-EBITDA for today is calculated as:

ME Therapeutics Holding's current Enterprise Value is C$103.19 Mil.
ME Therapeutics Holding's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-6.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding  (XCNQ:METX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ME Therapeutics Holding's PE Ratio for today is calculated as:

ME Therapeutics Holding's share price for today is C$4.11.
ME Therapeutics Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.296.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

ME Therapeutics Holding EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description